Dr. Stephen Chanock, M.D., Chief of the Laboratory of Translational Genomics in the Division of Cancer Epidemiology and Genetics, discusses insights from cancer genome-wide association studies. Explore the genomic approaches used in identifying and characterizing cancer susceptibility regions in the human genome, and future trends in this research. This seminar was presented at the Hefei 2011 GWAS workshop in Anhui, China. The workshop was supported by Nature Genetics and by Anhui Medical University.
Also read the accompanying commentary Milestone in Anhui in Nature Genetics.
Nature Medicine discusses new genetic variations that help predict second cancers after radiation therapy for Hodgkin's lymphoma. Listen to the August 2011 podcast "Collateral Cancer" with NCI's Dr. Stephen Chanock at Nature Medicine.
Also, read the accompanying article A step toward slaying the hydra of second cancers by Drs. Lindsey Morton and Stephen Chanock in Nature Medicine News and Views.
New ion-sensing method offers quick and inexpensive technology for genome sequencing. Read the article Chip chips away at the cost of a genome, in Nature News.
Q&A: NCI’s Stephen Chanock on the Three Waves of Genome-Wide Association Studies , read the interview on GenomeWeb, March 2011